Revance Therapeutics Inc (RVNC)

May 16, 2025

Price T Rowe Associates Inc. MD Purchases 7,839 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 16, 2025

May 14, 2025

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - ACCESS Newswire

May 14, 2025

May 14, 2025

Dermata Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 13, 2025

Revance Therapeutics (NASDAQ:RVNC) Now Covered by StockNews.com - Defense World

May 13, 2025

May 13, 2025

Hsbc Holdings PLC Cuts Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 13, 2025

May 12, 2025

Lost Money on Revance Therapeutics, Inc. (RVNC)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 12, 2025

May 11, 2025

Shareholders that Lost Money on Revance Therapeutics, Inc. (RVNC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 11, 2025

May 10, 2025

Revance Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire

May 10, 2025

May 10, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Acquired by Wells Fargo & Company MN - Defense World

May 10, 2025

May 10, 2025

Revance Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationRVNC - ACCESS Newswire

May 10, 2025

May 09, 2025

MetLife Investment Management LLC Has $184,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 09, 2025

May 09, 2025

Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) PT at $8.39 - Defense World

May 09, 2025

May 05, 2025

Invesco Ltd. Boosts Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

May 05, 2025

May 05, 2025

Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com - Defense World

May 05, 2025

May 02, 2025

Spasticity Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Jazz Pharmaceuticals, Revance Therapeutics, Ipsen - Barchart.com

May 02, 2025

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025

May 02, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Sold by LPL Financial LLC - Defense World

May 02, 2025

May 01, 2025

Revance Announces Blue Lizard® Australian Sunscreen Named the #1 Selling Mineral Sunscreen Brand - Longview News-Journal

May 01, 2025

Apr 27, 2025

Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com - Defense World

Apr 27, 2025

Apr 25, 2025

Geode Capital Management LLC Raises Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 25, 2025

Apr 24, 2025

Investigation announced for Long-Term Investors in Revance - openPR.com

Apr 24, 2025

Apr 24, 2025

Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com

Apr 24, 2025

Apr 21, 2025

JPMorgan Chase & Co. Sells 2,335,359 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 21, 2025

Apr 21, 2025

Former Revance Therapeutics Leader Takes AEON Helm: Inside the Race to Challenge BOTOX's $3B Market - Stock Titan

Apr 21, 2025

Apr 17, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Sold by Vanguard Group Inc. - Defense World

Apr 17, 2025

Apr 15, 2025

Corebridge Financial Inc. Reduces Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 15, 2025

Apr 14, 2025

Wellington Management Group LLP Trims Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 14, 2025

Apr 13, 2025

Norges Bank Takes Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 13, 2025

Apr 12, 2025

KLP Kapitalforvaltning AS Takes Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 12, 2025

Apr 11, 2025

Commonwealth Equity Services LLC Cuts Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World

Apr 11, 2025

Apr 11, 2025

Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Recommendation of “Hold” from Analysts - Defense World

Apr 11, 2025

Apr 11, 2025

StockNews.com Initiates Coverage on Revance Therapeutics (NASDAQ:RVNC) - Defense World

Apr 11, 2025

Apr 09, 2025

BIOJUVE® Honoured as Best Cosmetics of the Year at AMWC 2025 in Monaco - The Malaysian Reserve

Apr 09, 2025

Apr 09, 2025

Public market insider buying at Prime Mining (PRYM) - The Globe and Mail

Apr 09, 2025

Apr 06, 2025

RVNC INVESTIGATION: Hagens Berman Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations - ACCESS Newswire

Apr 06, 2025

Apr 04, 2025

RVNC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Revance Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Bay Area drug veteran heads New Zealand company's oral ketamine spinoff targeting depression - The Business Journals

Apr 04, 2025

Apr 02, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022RVNC - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Crown Laboratories rebrands as Revance following acquisition - MSN

Apr 01, 2025